<?xml version="1.0" encoding="UTF-8"?>
<p>Overall assessment. Its traditional use as cough therapy in the context of upper respiratory conditions is not backed up by robust clinical data profile, but its safety profile allows for potential use in the relief of early symptoms of COVID-19. The clinical evidence may be considered High. Even though 
 <italic>P. anisum</italic> has potential antiplatelet effects, overall, it can be considered presenting Medium safety.
</p>
